Meanwhile, people are growing increasingly complacent about getting inoculated as infections and deaths have fallen sharply in the past month. Serum Institute of India, which produces Covishield, has nearly quadrupled its capacity since April and can now produce up to 240 million vaccine doses monthly. A government study in July estimated that more than two-thirds of Indians already had COVID-fighting antibodies, mainly through natural infection. About 75% of India's adult population have received at least one COVID-19 dose, while 31% are fully vaccinated, according to government data. "Within the next 4-6 weeks after that, second doses will also be given."

Source: bd News24 October 23, 2021 02:18 UTC